Frederique M. Llorca-Penault

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 341 publications

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 15, 2026

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

Journal: European urology oncology

Published: May 05, 2026

New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice.

New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practice.

Journal: Breast (Edinburgh, Scotland)

Published: April 08, 2026

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.

Journal: Breast (Edinburgh, Scotland)

Published: March 19, 2026

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Journal: Breast (Edinburgh, Scotland)

Published: March 12, 2026

Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma.

Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 03, 2026

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.

Diagnosis and treatment of human epidermal growth factor receptor 2-positive metastatic colorectal cancer: a systematic literature review.

Journal: Cancer treatment reviews

Published: November 25, 2025

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Journal: The Lancet. Oncology

Published: November 17, 2025

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies.

Journal: Scientific reports

Published: October 20, 2025

Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 07, 2025

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Showing 1-12 of 341

Last Updated: 09/26/2026